Drugmaker Shire bids $30 billion for Baxter spin-off Baxalta
Drugmaker Shire said on Tuesday it was seeking to buy Baxalta , a company spun-off by Baxter International last month, for $30 billion to forge the leading global specialist in rare diseases.
Aug 05, 2015, 11:37 AM IST